WVE Wave Life Sciences, Inc.: institutional ownership and insider trading
234 funds reported holding $1.13B of Wave Life Sciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $35.3M, with 47 new positions and 41 funds selling out; over the last 12 months insiders bought $82.6M and sold $16.2M on the open market.
Famous investors holding WVE
- Lee Ainslie (Maverick Capital): $59.7M, 0.5% of the portfolio
- Two Sigma (Two Sigma Investments): $21.5M, 0.0% of the portfolio
- Stanley Druckenmiller (Duquesne Family Office): $1.01M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $9.90M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $10.5M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $10.3M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.59M, 0.0% of the portfolio
Largest institutional holders of WVE
- RA CAPITAL MANAGEMENT, L.P. — $157M
- BlackRock, Inc. (BLK) — $112M
- GSK plc (GSK, GLAXF) — $106M
- VANGUARD GROUP INC — $60.8M
- MAVERICK CAPITAL LTD — $59.7M
- DRIEHAUS CAPITAL MANAGEMENT LLC — $31.6M
- PRIMECAP MANAGEMENT CO/CA/ — $31.1M
- 683 Capital Management, LLC — $28.8M
- FMR LLC — $28.6M
- STATE STREET CORP (STT, STT-PG) — $28.1M
Recent WVE insider trades
- Aug 12, 2026: Rawcliffe Adrian sold 12,700 shares ($67.2K)
- Aug 11, 2026: Tan Aik Na sold 432 shares ($2.60K)
- Aug 11, 2026: Takanashi Ken sold 3,864 shares ($23.2K)
- Aug 11, 2026: Wagner Heidi L sold 7,000 shares ($42.1K)
5%+ owners
- RA Capital Management, L.P.: 17.1% (Schedule 13D/A, filed Apr 17, 2026)